Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldebain for Pain Management After Knee Arthroplasty
NCT05266027Phase 4Completed
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Apr 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dinalbuphine sebacate in postoperative pain, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Started Apr 2022; status: completed.
02
Drugs
dinalbuphine sebacate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05266027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266027.